The Hair Loss Encyclopedia

Search

for
Search:

GlossaryTocilizumab

medication that inhibits IL-6 receptor to reduce inflammation

Tocilizumab, also known by the brand name Actemra, is a medication that targets the interleukin-6 (IL-6) receptor, which plays a role in the body's immune response. It is commonly used to treat autoimmune conditions such as rheumatoid arthritis and has also been explored for use in managing severe cases of COVID-19. By inhibiting IL-6, Tocilizumab helps reduce inflammation and modulate the immune system.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 112 results

Hair Growth in a Patient with Alopecia Areata on Tocilizumab

research Hair Growth in a Patient with Alopecia Areata on Tocilizumab

1 citations , January 2021 in “Skin appendage disorders”

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Adverse Effects and Drug Interactions of Biologic Agents

research Adverse Effects and Drug Interactions of Biologic Agents

March 2010 in “Anti-inflammatory & anti-allergy agents in medicinal chemistry”

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Hair-Cycle Changes in Two Patients Taking Tocilizumab

research Hair-Cycle Changes in Two Patients Taking Tocilizumab

6 citations , August 2013 in “Joint Bone Spine”

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Halo Nevi, Vitiligo, and Diffuse Alopecia Areata Associated with Tocilizumab Therapy

research Halo Nevi, Vitiligo, and Diffuse Alopecia Areata Associated with Tocilizumab Therapy

10 citations , August 2016 in “Oxford Medical Case Reports”

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Commonalities Between COVID-19 and Radiation Injury

research Commonalities Between COVID-19 and Radiation Injury

18 citations , October 2020 in “Radiation Research”

Some drugs may help treat both COVID-19 and radiation injury.

View more "tocilizumab" in research →

Community Join

0 / 0 results

— no results